The World's First Malaria Vaccine Is Headed to Kenya, Ghana and Malawi according to : Health US News

Blood pressure basicsBlood pressure basics (iStockPhoto) "It's a straightforward, simple thing, but tracking blood pressure is important throughout our lives," Levy says. Routine blood work offered in her practice involves a prostate-specific antigen blood test (a PSA test) and a prostate exam. "The great thing about cervical cancer screening is we're preventing cancer," Levy says, not just detecting existing disease. High blood pressure is a risk factor for heart attacks, strokes, heart failure, kidney disease and other disorders. During a checkup, you can talk about lifestyle changes to lower your blood pressure, such as exercising and following the DASH diet.




London: Ghana, Kenya and Malawi will pilot the world's first malaria Vaccine from 2018, offering it for babies and children in high-risk areas as part of real-life trials, WHO said on Monday. Share this:PrintMoreEmailPocketThe injectable vaccine was developed by British drugmaker GlaxoSmithKline to protect children from the most deadly form of malaria in Africa. RTS,S was developed by GSK in partnership with the non-profit PATH Malaria Vaccine Initiative and part-funded by the Bill & Melinda Gates Foundation. The injectable vaccine, called RTSS or Mosquirix, was developed by British drugmaker GlaxoSmithKline to protect children from the most deadly form of malaria in Africa. The WHO said Malawi, Kenya and Ghana were chosen for the pilot due to several factors, including having high rates of malaria as well as good malaria programmes, wide use of bed-nets, and well-functioning immunisation programmes.

Kenya, Ghana, Malawi Chosen for Breakthrough Malaria Vaccine Trial

The World Health Organization has announced that trials of a new malaria vaccine will take place in three African countries – Kenya, Ghana and Malawi. The announcement was made ahead of the U.N.'s World Malaria Day Tuesday – and the chosen theme for this year is 'a push for prevention'. It's hoped that 360,000 children will be vaccinated between 2018 and 2020 in Kenya, Ghana and Malawi. "Currently the majority of control is through the use of bed nets, but there's an increasing fear that mosquitoes are becoming resistant to some of the insecticide on those bed nets," he said. "The recent studies show that it's partially effective, and that that effectiveness wears off quite quickly over time."The $50 million trials in Ghana, Kenya and Malawi are being funded through a network of NGOs and global institutions.


collected by :Lucy William

To follow all the new news about Health care